Malaga Cove Capital, LLC Acelrx Pharmaceuticals Inc Transaction History

Malaga Cove Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$2.13 - $4.2 $62,089 - $122,430	-29,150 Closed	0 $0
Q1 2018 Apr 16, 2018	BUY	$1.7 - $2.35 $49,555 - $68,502	29,150 New	29,150 $61,000
Q4 2017 Jan 31, 2018	SELL	$1.75 - $5.5 $23,012 - $72,325	-13,150 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$2.9 - $4.6 $38,135 - $60,489	13,150	13,150 $72,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.